day 1 agenda

6th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA
at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event)
Day -1(October 01, 2025)
Tentative Program
Talk-1 KeynoteTalk: Novel Tau-specific aptamers : diagnostic and therapeutic potentials
Kevin K. Wang, CNMB, USA
Talk-2 KeynoteTalk: Can a selective calpain-2 inhibitor be used for the treatment of Alzheimer’s Disease?
Michel Baudry, Western University of Health Sciences , USA
Talk-3 KeynoteTalk: TBA
José Julio Rodríguez Arellano, IKERBASQUE, Spain
Refreshment Break
Talk-4 Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
Amanda J. Myers, University of Miami, USA
Talk-5 Slot Available
Talk-6 A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
Alison Buchholz, The Johns Hopkins University School of Medicine, USA
Talk-7 The associations of daytime napping and motoric cognitive risk syndrome: Findings from the China Health and Retirement Longitudinal Study.
Xiaolei Liu, West China Hospital, Sichuan University, China
Talk-8 The role of early cerebral edema and hematoma assessment in aneurysmal subarachnoid hemorrhage (a-SAH) in predicting early brain injury (EBI) and cognitive impairment: a case controlled study
Mingdong Wang, The First Hospital of Hebei Medical University/Hebei Hospital of Xuanwu Hospital Capital Medical University, China
Talk-9 Slot Available
Talk-10 Potential association of neuronal membrane cholesterol and APP levels with astrocytic de novo cholesterol synthesis, influenced by sex-dependent sublethal copper concentration
Arnal Nathalie, INIBIOLP, Argentina
Lunch Break@Restuarant
Talk-11 ‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease
Raja Banerjee, MAKAUT, India
Talk-12 Electromagnetic field stimulation ameliorates cognitive deficits and induces neurogenesis in Alzheimer’s disease rat model
Suman Jain, AIIMS, India
Talk-13 Slot Available
Talk-14 Structural Changes in Cerebral Microvasculature Induced by Ferroptosis Contribute to Blood–Brain Barrier Destruction in Alzheimer's Disease: An Autopsy Study
Yuan Cao, Peking Union Medical College Hospital, China
Talk-15 Slot Available
Talk-16 Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Clifford R. Jack, Mayo Clinic, USA
Talk-17 Verbal training can improve neurocognitive and reading performance by increasing white matter integrity and grey matter volume
Ching-Chi Hsu, Wizcare Medical Corporation Aggregate, Taiwan
Talk-18 Slot Available
Talk-19 P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little?
Caroline Jose,Vital ité Health Network, , Canada
Refreshment Break
Talk-20 Pain & Ageing: Where are we now and what needs to be done?
Pat Schofield, University of Plymouth, UK
Talk-21 Slot Available
Talk-22 Associations of combined accelerated biological aging and genetic susceptibility with incident dementia: a prospective study in the UK Biobank
Jiawei Xin, Fujian Medical University , China
Abstract submissions are open, please email: dementiacongress@innovinc.org
Day-1 Concludes

day 2 agenda

Will be Updated soon...

Download